🔎 Trials Near Me

Home › Biliary Tract Cancer › Maryland › Baltimore

Biliary Tract Cancer clinical trials in Baltimore, MD

8 studies for Biliary Tract Cancer are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

RecruitingPhase 3
  • Research Site, Baltimore
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07221253

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

RecruitingPhase 1
  • United Theranostics, Glen Burnie · 9 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07812805

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

RecruitingPhase 3
  • Research Site, Towson · 8 mi away
Ages 18 to 99 · All sexes · Updated Aug 19, 2026 · NCT06467357

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2
  • The John Hopkins Hospital, Baltimore
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

RecruitingPhase 1
  • SKCCC Johns Hopkins Medical Institution, Baltimore
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06564623

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

RecruitingPhase 2
  • University of Maryland Medical Center, Baltimore
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT05733598

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

RecruitingPhase 1
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland Greenebaum Cancer Center, Baltimore
Ages 21 and older · All sexes · Updated Dec 10, 2025 · NCT06546969

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

RecruitingPhase 2
  • SKCCC Johns Hopkins, Baltimore
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT06001658

Biliary Tract Cancer trials in other cities

Other studies in Baltimore

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.